Ergoferon Tab ... for resorption No. 20

ERGOFERONВ® has an enhanced effect due to its antiviral, anti-inflammatory and antihistamine effects.

This combination allows you to quickly cope with viruses, reduce the symptoms of influenza and SARS and speed up recovery.

ERGOFERONВ® is effective at all stages of the disease: the first signs of the disease, the extended stage of the disease, the stage of complications.

In the course of clinical trials, ERGOFERONВ® has confirmed its high efficacy and safety combined with the absence of side effects.

ERGOFERONВ® is specially designed for people with an active lifestyle who do not have time to get sick.

Name ENG

ERGOFERON

Clinical and pharmacological group

Antiviral drug, Immunomodulating drug, Antihistamine

ATX code

Other antiviral drugs, Antihistamines for systemic use

Dosage

6mg + 6mg + 6mg

Structure

1 tablet contains: antibodies to human gamma interferon affinity purified - 0.006 g *, antibodies to histamine affinity purified - 0.006 g *, antibodies to CD4 affinity purified - 0.006 g *.

Excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

* applied to lactose in the form of a mixture of three active aqueous-alcoholic dilutions of the substance, diluted 10012, 10030, 10050 times, respectively.

Indications

Prevention and treatment of influenza A and B (including bird flu A / H5N1 and swine flu A / H1N1).

- Prevention and treatment of enteroviral and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis.

- Application in the complex therapy of bacterial infections (pseudotuberculosis, whooping cough, yersiniosis, pneumonia of various etiologies, including those caused by atypical pathogens (M. pneumoniae, C. Pneumoniae, Legionella spp))

prevention of bacterial complications of viral infections, prevention of superinfections.

- Prevention and treatment of acute respiratory viral infections caused by parainfluenza virus, adenovirus, respiratory syncytial virus, coronavirus.

- Prevention and treatment of herpesvirus infections (labial herpes, ophthalmic herpes, genital herpes, chickenpox, herpes zoster, infectious mononucleosis).

- Prevention and treatment of acute intestinal infections of viral etiology (caused by calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses). I2147

Contraindications

Increased individual sensitivity to drug components.

Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Children up to age 6 months

INN / Active ingredient

Antibodies To Histamine Affinity Purified, Antibodies To Cd4 Affinity Purified, Antibodies To Human Gamma Interferon Affinity Purified

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

Specifications

Category

Antiviral

,

Immunomodulators

Scope of the drug

The immune system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Minimum age from

6 months

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antiviral agent

Anatomical and therapeutic characteristics

J05AX Other antiviral drugs

Dosage form

Lozenges

Expiration date in days

1095

The target audience

Children

Package weight, g

ten

Mode of application

:

Inside. At one time - 1 tablet (not with meals). The tablet should be kept in the mouth without swallowing until it is completely dissolved. Film For children from 6 months. When prescribing the drug to young children (from 6 months to 3 years), it is recommended to dissolve the tablet in a small amount (1 tablespoon) of boiled water at room temperature. < br> Treatment should be started as early as possible, when the first signs of an acute infection appear according to the following scheme: in the first 2 hours, the drug is taken every 30 minutes, then during the first day, three more doses are taken at regular intervals. From the second day onwards, take 1 tablet 3 times a day until complete recovery. < br> For the prevention of viral infectious diseases - 1-2 tablets a day. < br> The recommended duration of the prophylactic course is determined individually and can be 1 - 6 months. < br> If necessary, the drug can be combined with other antiviral and symptomatic agents. < br>

Dosage (volume) of the substance in the preparation

:

Affinity purified antibodies to human interferon gamma 6 mg, affinity purified antibodies to histamine 6 mg, affinity purified antibodies to CD4 6 mg